Assignee
INFACARE PHARMACEUTICAL CORP
US·11 granted patents·4 pending applications·65 citations·filing 2004–2019
Top patents by PatentIndex Score
15 records- 0193US7960371B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2007·Granted Jun 14, 2011·15 cites·31 claims
- 0290US7777028B2Preparation of metal mesoporphyrin compoundsINFACARE PHARMACEUTICAL CORP·Filed 2007·Granted Aug 17, 2010·10 cites·14 claims
- 0389US9107927B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2014·Granted Aug 18, 2015·8 cites·20 claims
- 0488US8835416B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2013·Granted Sep 16, 2014·6 cites·20 claims
- 0588US7375216B2Preparation of metal mesoporphyrin compoundsINFACARE PHARMACEUTICAL CORP·Filed 2004·Granted May 20, 2008·22 cites·36 claims
- 0683US10273255B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2018·Granted Apr 30, 2019·2 cites·3 claims
- 0783US9902745B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2016·Granted Feb 27, 2018·2 cites·16 claims
- 0870US10533024B2Methods for synthesizing metal mesoporphyrinsINFACARE PHARMACEUTICAL CORP·Filed 2018·Granted Jan 14, 2020·0 cites·5 claims
- 0968US9181285B2Methods for synthesizing metal mesoporphyrinsINFACARE PHARMACEUTICAL CORP·Filed 2014·Granted Nov 10, 2015·0 cites·4 claims
- 1062US2017260217A1Methods for synthesizing metal mesoporphyrinsINFACARE PHARMACEUTICAL CORP·Filed 2017·Application pending·0 cites
- 1161US9688705B2Methods for synthesizing metal mesoporphyrinsINFACARE PHARMACEUTICAL CORP·Filed 2015·Granted Jun 27, 2017·0 cites·6 claims
- 1261US9517239B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2015·Granted Dec 13, 2016·0 cites·16 claims
- 1335US2020016167A1Methods for Treating Hyperbilirubinemia with StannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 1431US2013158362A1Methods for treating hyperbilirubinemia with stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2012·Application pending·0 cites
- 1527US2020001109A1Methods For Treating Hyperbilirubinemia With Stannsoporfin And PhototherapyINFACARE PHARMACEUTICAL CORP·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INFACARE PHARMACEUTICAL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →